G

Garvan Institute of Medical Research

Genetic disease-focused biomedical research institute

Research Officer

Full-Time
A$102.5k - A$117.4k/yr+ 14% superannuation + Salary packaging
Mid
PhD
Sydney NSW, Australia
Remote
Academic & Institutional ResearchLife Sciences Research

About the job

Requirements
  • A PhD in Genetics, Molecular Biology, Cellular Biology, or a related field is required.
  • Demonstrated experience in stem cell culture and differentiation systems, or computational analysis of genomic data from stem cell culture and differentiation systems, is required.
  • Proven experience applying genetic and molecular approaches to investigate biological mechanisms is required.
  • Experience with CRISPR-based methods, single-cell technologies, or functional genomics assays is required.
  • A strong publication record and evidence of independent research capability are required.
  • Commitment to research integrity, reproducibility, and laboratory safety is required.
  • Strong problem-solving, organisational, and communication skills are required.
Responsibilities
  • Design and analyse experiments using human induced pluripotent stem cells and derived cell types to study gene regulation, differentiation, and disease mechanisms, with a wet-lab or dry-lab focus depending on the candidate’s background.
  • Apply molecular and cellular biology techniques, including genome editing, CRISPR, transcriptomics, and high-content imaging, to investigate gene function.
  • Integrate genetic and functional genomics data to identify regulatory pathways and causal variants.
  • Develop and optimise experimental pipelines linking genetic perturbation to cellular phenotype.
  • Produce research outputs suitable for publication in peer-reviewed journals and contribute to competitive grant proposals.
  • Present findings in seminars, internal meetings, and national or international conferences.
  • Supervise and mentor research assistants and students, fostering technical excellence and professional growth.
  • Assist in planning and managing research projects and ensure compliance with institutional ethics, biosafety, and governance requirements.
  • Collaborate with computational biologists, clinicians, and other scientists to interpret genetic data and translate findings into biological insight.
  • Contribute to new research directions and pilot projects that expand program capabilities.
Desired Qualifications
  • Experience in grant writing.
  • Good knowledge of statistics and presentation of single-cell molecular data.
  • Capacity to work collaboratively across dry and wet laboratories.
  • Experience with cell functional assays such as proteomics, cell painting, and physiology.
  • Experience with cell model systems such as organoids or lab-on-chip models.

About the company

G

Garvan Institute of Medical Research

View

Garvan Institute of Medical Research conducts biomedical research to understand how genes, molecules, and cells influence health and disease, aiming to prevent and treat major illnesses. It combines fundamental science with strong clinical collaborations to translate discoveries into medical advances. What sets Garvan apart is its sustained, long-term work that integrates laboratory research with direct clinical interactions across a range of diseases, not just one specialty. Its goal is to prevent, treat, or cure major diseases such as cancer, diabetes/obesity, neurological disorders, osteoporosis, and immunological diseases by uncovering mechanisms and developing new therapies.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Sydney, Australia

Founded

1963

Get referred to Garvan Institute of Medical Research

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • NHMRC awarded Garvan’s autoimmune centre funding on 7 September 2026, extending five-year support.
  • Garvan secured NHMRC funding boosts on 10 August 2026 for genomic and immune discoveries.
  • Garvan announced new cancer labs and recruitment in August 2026, signaling continued scientific expansion.

What critics are saying

  • Garvan’s revenue depends on grants and philanthropy; one funding gap can freeze programs quickly.
  • Revelio shows 663 employees in March 2026 and only 16 postings, signaling hiring caution.
  • If translational bets like PatientSeek or CAR-T fail, Garvan remains a research-only cost center.

What makes Garvan Institute of Medical Research unique

  • Garvan’s autoimmune CRE under Chris Goodnow targets somatic mutation biology, not generic immunology.
  • Its Genomics Platform joined Parse Biosciences in July 2026, expanding regional single-cell access.
  • Garvan pairs discovery research with clinical trial networks, including Parkinson’s stratification and cancer studies.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Parental Leave
  • Flexible Work Hours
  • Professional Development Budget
  • Conference Attendance Budget
  • Employee Discounts

Company News

BioSpace
Feb 22nd, 2023
C4Xd And Garvan Institute Of Medical Research Report Successful Patient Stratification Approach Using C4Xd'S New Precision Medicine Platform Patientseek

First validation of C4XD's patient sub-groups through a Garvan-led retrospective clinical trial analysis. Promising initial result paves way for novel approaches in Parkinson's disease stratification. Launch of PatientSeek platform enables stratification of patients to identify the right patient for the right medicine